|
|
Moderna, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: Advantage, mRNA One hopes the the FDA and its expert panel realize the solution to this NVAX problem is not to choose strains earlier but for NVAX to either speed up their manufacturing or enter the market later. |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 18211 | Re: Advantage, mRNA | dar200 | 0 | 1/27/2023 8:17:43 PM |
